XC

Xiaoyan Chu

Merck & Co., Inc., Rahway, NJ, USA (United States) US

ORCID 0000-0001-7223-9000
123
Publications
10,152
Citations
47
H-Index
87
i10-Index
27.25
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

No publications found.

Research Topics

Drug Transport and Resistance Mechanisms (82) Pharmacological Effects and Toxicity Studies (45) Pharmacogenetics and Drug Metabolism (33) HIV/AIDS drug development and treatment (14) Liver Disease Diagnosis and Treatment (13)

Affiliations

AstraZeneca (United Kingdom)
GB 2013 - 2013
Délégation Paris 5
FR 2016 - 2016
Roche (Switzerland)
CH 2013 - 2013
Merck & Co., Inc., Rahway, NJ, USA (United States)
US 2025 - 2004
Biogen (United States)
US 2020 - 2013

Share Profile

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now